Kalin Katherine Bach 4
4 · SELLAS Life Sciences Group, Inc. · Filed Jan 25, 2024
Insider Transaction Report
Form 4
Kalin Katherine Bach
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-01-22+10,000→ 10,000 totalExercise: $0.52Exp: 2034-01-22→ Common Stock (10,000 underlying) - Award
Common Stock
2024-01-22+6,000→ 8,500 total
Footnotes (2)
- [F1]The Reporting Person received an award of 6,000 restricted stock units on January 22, 2024, which shall vest in full on December 1, 2024, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date.
- [F2]The shares subject to the option will fully vest on the earlier of (x) January 22, 2025 (the first anniversary of the date of grant) or (y) the business day prior to the 2025 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date.